172 related articles for article (PubMed ID: 15816854)
1. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model.
Chou SY; Lee YC; Chen HM; Chiang MC; Lai HL; Chang HH; Wu YC; Sun CN; Chien CL; Lin YS; Wang SC; Tung YY; Chang C; Chern Y
J Neurochem; 2005 Apr; 93(2):310-20. PubMed ID: 15816854
[TBL] [Abstract][Full Text] [Related]
2. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.
Chiang MC; Chen HM; Lai HL; Chen HW; Chou SY; Chen CM; Tsai FJ; Chern Y
Hum Mol Genet; 2009 Aug; 18(16):2929-42. PubMed ID: 19443488
[TBL] [Abstract][Full Text] [Related]
3. Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice.
Martire A; Calamandrei G; Felici F; Scattoni ML; Lastoria G; Domenici MR; Tebano MT; Popoli P
Neurosci Lett; 2007 Apr; 417(1):78-83. PubMed ID: 17331645
[TBL] [Abstract][Full Text] [Related]
4. Influence of CGS 21680, a selective adenosine A(2A) receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice.
Ferrante A; Martire A; Armida M; Chiodi V; Pézzola A; Potenza RL; Domenici MR; Popoli P
Brain Res; 2010 Apr; 1323():184-91. PubMed ID: 20138162
[TBL] [Abstract][Full Text] [Related]
5. Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms.
Bailey CD; Johnson GV
J Neurochem; 2005 Jan; 92(1):83-92. PubMed ID: 15606898
[TBL] [Abstract][Full Text] [Related]
6. Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease.
Josefsen K; Nielsen MD; Jørgensen KH; Bock T; Nørremølle A; Sørensen SA; Naver B; Hasholt L
J Neuroendocrinol; 2008 Feb; 20(2):165-72. PubMed ID: 18034868
[TBL] [Abstract][Full Text] [Related]
7. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
[TBL] [Abstract][Full Text] [Related]
9. Global changes to the ubiquitin system in Huntington's disease.
Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
[TBL] [Abstract][Full Text] [Related]
10. Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation.
Zourlidou A; Gidalevitz T; Kristiansen M; Landles C; Woodman B; Wells DJ; Latchman DS; de Belleroche J; Tabrizi SJ; Morimoto RI; Bates GP
Hum Mol Genet; 2007 May; 16(9):1078-90. PubMed ID: 17360721
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
Popovic N; Maingay M; Kirik D; Brundin P
Exp Neurol; 2005 May; 193(1):65-74. PubMed ID: 15817265
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tetrathiomolybdate in the R6/2 model of Huntington disease.
Tallaksen-Greene SJ; Janiszewska A; Benton K; Hou G; Dick R; Brewer GJ; Albin RL
Neurosci Lett; 2009 Mar; 452(1):60-2. PubMed ID: 19429000
[TBL] [Abstract][Full Text] [Related]
13. IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
Duarte AI; Petit GH; Ranganathan S; Li JY; Oliveira CR; Brundin P; Björkqvist M; Rego AC
Exp Neurol; 2011 Oct; 231(2):314-9. PubMed ID: 21763311
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.
Domenici MR; Scattoni ML; Martire A; Lastoria G; Potenza RL; Borioni A; Venerosi A; Calamandrei G; Popoli P
Neurobiol Dis; 2007 Nov; 28(2):197-205. PubMed ID: 17720507
[TBL] [Abstract][Full Text] [Related]
15. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
Crocker SF; Costain WJ; Robertson HA
Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
[TBL] [Abstract][Full Text] [Related]
16. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease.
Gil JM; Rego AC
Brain Res Rev; 2009 Mar; 59(2):410-31. PubMed ID: 19118572
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
Petersén A; Chase K; Puschban Z; DiFiglia M; Brundin P; Aronin N
Exp Neurol; 2002 May; 175(1):297-300. PubMed ID: 12009780
[TBL] [Abstract][Full Text] [Related]
18. Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice.
Denovan-Wright EM; Attis M; Rodriguez-Lebron E; Mandel RJ
J Neurosci Res; 2008 Jun; 86(8):1748-57. PubMed ID: 18293418
[TBL] [Abstract][Full Text] [Related]
19. The novel substituted pyrimidine, KP544, reduces motor deficits in the R6/2 transgenic mouse model of Huntington's disease.
Dey ND; Boersen AJ; Myers RA; York LR; Bombard MC; Lu M; Sandstrom MI; Hulce VD; Lescaudron L; Dunbar GL
Restor Neurol Neurosci; 2007; 25(5-6):485-92. PubMed ID: 18334766
[TBL] [Abstract][Full Text] [Related]
20. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease.
Jenkins BG; Andreassen OA; Dedeoglu A; Leavitt B; Hayden M; Borchelt D; Ross CA; Ferrante RJ; Beal MF
J Neurochem; 2005 Oct; 95(2):553-62. PubMed ID: 16135087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
